Interestingly, the activities of members of the RISK pathway, including Akt, ERK1/2, and GSK-3β, are often impaired in conditions of diabetes, obesity, insulin resistance, and hypercholesterolemia [3, 16, 29, 30]. Here, MAPK3 is linked to obesity disorder.